Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation
Institute for Clinical and Experimental Medicine
Institute for Clinical and Experimental Medicine
The Royal Wolverhampton Hospitals NHS Trust
NHS Blood and Transplant
National Cancer Center, Korea
Nakhon Phanom Hospital
Instituto Nacional de Cancer, Brazil
Norwegian Institute of Public Health
National Institute of Cancerología
Manchester University NHS Foundation Trust
Instituto Nacional del Cáncer, Argentina
Sheba Medical Center
Turku University Hospital
Turku University Hospital
Tata Memorial Hospital
Norwegian Department of Health and Social Affairs
Sheba Medical Center
Centro de Investigación en. Enfermedades Infecciosas, Mexico
Instituto Nacional de Cancer, Brazil
Centro Superior de Investigación en Salud Publica
East and North Hertfordshire NHS Trust